Try a new search

Format these results:

Searched for:

person:rsg1

Total Results:

68


Ambulatory Anesthesia

Chapter by: Karlis, Vasiliki; Bourell, Lauren; Glickman, Robert
in: Management of Complications in Oral and Maxillofacial Surgery by
[S.l.] : wiley, 2022
pp. 1-23
ISBN: 9781119710691
CID: 5460182

Robotic Assisted Drilling Systems and Prosthetically-Driven Implant Rehabilitation: The Present and Future?

Rekawek, Peter; Sastow-Robbins, Tal; Glickman, Robert
PMID: 34171223
ISSN: 1531-5053
CID: 5044242

Protective Measures against COVID-19: Dental Practice and Infection Control

Induri, Sri Nitya Reddy; Chun, Yunah Caroline; Chun, Joonmo Christopher; Fleisher, Kenneth E; Glickman, Robert S; Xu, Fangxi; Ioannidou, Efthimia; Li, Xin; Saxena, Deepak
The onset of the Coronavirus 2019 (COVID-19) pandemic has challenged the worldwide healthcare sector, including dentistry. The highly infectious nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and risk of transmission through aerosol generating procedures has profoundly impacted the delivery of dental care services globally. As dental practices with renewed infection control strategies and preventive measures are re-opening in the "new normal" period, it is the responsibility of healthcare professionals to constantly analyze new data and limit the spread of COVID-19 in dental care settings. In the light of new variants of SARS-CoV-2 rapidly emerging in different geographic locations, there is an urgent need to comply more than ever with the rigorous public health measures to mitigate COVID-19 transmission. The aim of this article is to provide dental clinicians with essential information regarding the spread of SARS-CoV-2 virus and protective measures against COVID-19 transmission in dental facilities. We complied and provided guidance and standard protocols recommended by credible national and international organizations. This review will serve as an aid to navigating through this unprecedented time with ease. Here we reviewed the available literature recommended for the best current practices that must be taken for a dental office to function safely and successfully.
PMCID:8230244
PMID: 34200036
ISSN: 2227-9032
CID: 4936982

Perspectives on meeting the COVID-19 testing challenge: A dental school collaborative

Donoff, R. Bruce; Poznansky, Mark; Kochman, David; Lieberthal, Bruce; Bhansali, Seema; Neale, Allison; Bryant, Daniel; Glickman, Robert; Moursi, Amr; Feldman, Cecile A.; Fine, Daniel; Kess, Steve; Alfano, Michael C.; Levy, Ari; Ismail, Amid; Rams, Thomas; Reddy, Michael; Gansky, Stuart; Ramneek, Rai; McCauley, Laurie K.; Eber, Robert; Wolff, Mark; Krumholz, Harlan
SCOPUS:85090117865
ISSN: 0022-0337
CID: 4612212

Medicaid Reimbursements for Coronectomy and Exodontia

Geiger, Joseph; Hesham, Abdulrahman; Sawatari, Yoh; Glickman, Robert
PMID: 32580880
ISSN: 1531-5053
CID: 4546252

Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy

Fleisher, Kenneth E; Janal, Malvin N; Albstein, Nicole; Young, James; Bikhazi, Vanessa; Schwalb, Shlomit; Wolff, Mark; Glickman, Robert S
OBJECTIVE:is associated with one or more particular comorbidities. STUDY DESIGN/METHODS:or DH lesion to a control patient who had a history of dentoalveolar surgery with uneventful healing and no history of antiresorptive therapy. Comorbidity data included medical conditions and smoking. RESULTS:and DH than in controls [M(SD) = 1.94 (1.2) and 2.0 (1.3) vs 1.26 (0.89); both P < .001]. CONCLUSIONS:and DH.
PMID: 30449690
ISSN: 2212-4411
CID: 3479252

Medication-related osteonecrosis of the jaw: Evidence for infection versus oversuppression. [Meeting Abstract]

Fleisher, Kenneth Evan; Muggia, Franco; Glickman, Robert S.
ISI:000487345802217
ISSN: 0732-183x
CID: 4125202

Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?

Fleisher, Kenneth E; Pham, Sabrina; Raad, Roy A; Friedman, Kent P; Ghesani, Munir; Chan, King Chong; Amintavakoli, Niloufar; Janal, Malvin; Levine, Jamie P; Glickman, Robert S
PURPOSE: There is considerable controversy over the treatment of medication-related osteonecrosis of the jaw (MRONJ) and growing interest and debate related to the timing, type, technique, and goals of surgical intervention. The specific aim was to evaluate the predictive value of fluorodeoxyglucose (FDG) positron emission tomography (PET) with computed tomography (CT) on healing outcomes in patients undergoing surgery for MRONJ of the mandible. MATERIALS AND METHODS: A retrospective cohort study of 31 patients with 33 MRONJ lesions of the mandible who had undergone surgery using FDG PET-CT was conducted. Data were collected on FDG uptake patterns, healing, follow-up, demographics, lesion characteristics, antiresorptive therapy, and adjunctive therapy. Panoramic and periapical radiographs were used to identify non-restorable teeth and PET-CT images were used to identify sequestra and FDG uptake. Above the mandibular canal, surgery consisted of marginal resection or debridement of clinically involved bone and exposure of clinically uninvolved bone identified by FDG uptake. Below the mandibular canal, mobile segments of bony sequestra were removed, but areas of clinically uninvolved bone with FDG uptake were not. Patients who did not heal underwent segmental resection and reconstruction with rigid fixation and a local or regional soft tissue flap or free fibular flap. The primary predictor variable was the FDG uptake pattern for each patient. The outcome variable was postoperative healing defined by mucosal closure without signs of infection or exposed bone at the time of evaluation. RESULTS: Two risk groups were identified based on FDG uptake pattern. The low-risk group, type A, included 22 patients with activity limited to the alveolus, torus, and basal bone superior to the mandibular canal. The high-risk group, type B, included 11 patients with type A FDG activity with extension inferior to the mandibular canal. Treatment of type A MRONJ lesions was more successful than treatment of type B MRONJ lesions (100 vs 27%; P < .001). Seven of the type B failures were successfully retreated by segmental resection and reconstruction (1 patient refused further treatment). CONCLUSION: These results showed that low-risk FDG PET-CT findings predicted successful healing with surgery above the mandibular canal. In contrast, high-risk FDG findings were associated with a greater than 50% risk of failure for treatment that extended below the mandibular canal. Although these failures suggest that FDG uptake indicates infected tissue, further research is needed to identify which high-risk patients are most likely to benefit from a conservative treatment protocol.
PMID: 26657395
ISSN: 1531-5053
CID: 1877702

Response of stem cells from different origins to biphasic calcium phosphate bioceramics

Lobo, Sonja E; Glickman, Robert; da Silva, Wagner N; Arinzeh, Treena L; Kerkis, Irina
Biphasic calcium phosphate (BCP) bioceramics have been successfully applied in a broad variety of presentation forms and with different ratios of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP). BCPs have been loaded with stem cells from different origins for bone tissue engineering purposes, but evidence of stem cell behavior on different compositions (various HA/beta-TCP ratios) and physical features of BCPs is limited. We compared the adhesion, proliferation, viability and osteogenic potential of human mesenchymal stem cells (MSCs) on granular BCPs with equal HA/beta-TCP ratio of diverse particle sizes and on porous blocks which had different chemical compositions. In addition, the osteogenic differentiation of MSCs was compared to adipose-derived (ADSC) and dental pulp (DPSC) stem cells, as well as to pre-osteoblasts on a particulate BCP. MSCs growing on granular BCPs demonstrated increased number as compared to MSCs growing on blocks. Cells proliferated to a greater extent on small granular BCPs, while large granular BCPs and blocks promoted cell differentiation. Surprisingly, the expression of genes involved in osteogenesis was upregulated in MSCs on bioceramics in basal medium which indicates that BCPs may have osteoinductive potential. This was confirmed with the upregulation of osteochondrogenic markers, at different time points, when stem cells from various tissues were grown on the BCP. This study demonstrates that BCPs, depending on their physical features and chemical composition, modulate stem cell behavior, and that stem cells from different origins are inherently distinct in their gene expression profile and can be triggered toward osteochondrogenic fate by BCPs.
PMCID:4529461
PMID: 25676006
ISSN: 1432-0878
CID: 1734902

Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw

Pushalkar, Smruti; Li, Xin; Kurago, Zoya; Ramanathapuram, Lalitha V; Matsumura, Satoko; Fleisher, Kenneth E; Glickman, Robert; Yan, Wenbo; Li, Yihong; Saxena, Deepak
Bacterial biofilms have emerged as potential critical triggers in the pathogenesis of bisphosphonate (BP)-related osteonecrosis of the jaw (ONJ) or BRONJ. BRONJ lesions have shown to be heavily colonized by oral bacteria, most of these difficult to cultivate and presents many clinical challenges. The purpose of this study was to characterize the bacterial diversity in BRONJ lesions and to determine host immune response. We examined tissue specimens from three cohorts (n=30); patients with periodontal disease without a history of BP therapy (Control, n=10), patients with periodontal disease having history of BP therapy but without ONJ (BP, n=5) and patients with BRONJ (BRONJ, n=15). Denaturing gradient gel electrophoresis of polymerase chain reaction (PCR)-amplified 16S rRNA gene fragments revealed less bacterial diversity in BRONJ than BP and Control cohorts. Sequence analysis detected six phyla with predominant affiliation to Firmicutes in BRONJ (71.6%), BP (70.3%) and Control (59.1%). Significant differences (P<0.05) in genera were observed, between Control/BP, Control/BRONJ and BP/BRONJ cohorts. Enzyme-linked immunosorbent assay (ELISA) results indicated that the levels of myeloperoxidase were significantly lower, whereas interleukin-6 and tumor necrosis factor-alpha levels were moderately elevated in BRONJ patients as compared to Controls. PCR array showed significant changes in BRONJ patients with downregulation of host genes, such as nucleotide-binding oligomerization domain containing protein 2, and cathepsin G, the key modulators for antibacterial response and upregulation of secretory leukocyte protease inhibitor, proteinase 3 and conserved helix-loop-helix ubiquitous kinase. The results suggest that colonization of unique bacterial communities coupled with deficient innate immune response is likely to impact the pathogenesis of ONJ.International Journal of Oral Science advance online publication, 8 August 2014; doi:10.1038/ijos.2014.46.
PMCID:5153588
PMID: 25105817
ISSN: 1674-2818
CID: 1122592